Biotechnology
Alexza Pharmaceuticals, Inc. announced today that it will present at the 161st American Psychiatric Association annual meeting the results of a Phase 2a clinical trial of Staccato loxapine for the treatment of acute agitation in schizophrenic patients. T
11:23 May 1, 2008
deCODE genetics today announced its consolidated financial results for the quarter ended March 31, 2008. A conference call to discuss the quarter's results and recent operating highlights will be webcast live tomorrow, Friday, May 2, at 8:00am Eastern Ti
11:13 May 1, 2008
Monogram Biosciences, Inc. today announced that the company's HER1 and HER3 Quantitative Protein Assays are now available for clinical development use. Built on Monogram's VeraTag platform, the HER1 and HER3 assays provide unique, quantitative measuremen
11:13 May 1, 2008
Cepheid today reported record revenue of $44.8 million for the first quarter of fiscal 2008, an increase of 76 percent over the first quarter of fiscal 2007. First quarter net loss was $1.9 million, or $ per share, on a GAAP basis; first quarter net inco
11:13 May 1, 2008
Stereotaxis, Inc. , announced today that Bevil J. Hogg, Chief Executive Officer, and James M. Stolze, Chief Financial Officer, will present at the Deutsche Bank 33rd Annual Health Care Conference inBoston on Wednesday, May 7, 2008 at 8:50 a.m. Eastern Ti
11:13 May 1, 2008
Telik, Inc. announced that its 2008 first quarter conference call and webcast will be held on Thursday, May 8, 2008 at 4:30 p.m. Eastern time following the release earlier that day of the company's financial results for the first quarter ended March 31,
11:13 May 1, 2008
Thoratec Corporation , a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today reported record quarterly revenues of $64.4 million for the first quarter of fiscal 2008.
11:03 May 1, 2008
Cambrex Corporation reports first quarter 2008 results for the period ended March 31, 2008.
11:03 May 1, 2008
InterMune, Inc. today announced results from operations for the first quarter ended March 31, 2008. InterMune reported a net loss for the first quarter of 2008 of $26.3 million, or $0.68 per share, compared with a net loss of $20.8 million, or $0.61 per
11:03 May 1, 2008
Monogram Biosciences, Inc. today reported financial results for the quarter ended March 31, 2008.
11:03 May 1, 2008
Pressure BioSciences, Inc. today announced that total revenue for the first quarter of 2008 was $132,376 compared to $131,621 for the comparable period in the prior year. Revenue from the sale of PCT products and services was $81,473 for the three months
11:03 May 1, 2008
Medivation, Inc. today reported on its corporate progress and financial results for the quarter ended March 31, 2008.
11:03 May 1, 2008
Kosan Biosciences Incorporated today reported financial results for the quarter ended March 31, 2008.
11:03 May 1, 2008
ABAXIS, Inc. , a medical products company manufacturing point-of-care blood analysis systems, today reported financial results for the fiscal quarter and the fiscal year ended March 31, 2008.
11:03 May 1, 2008
Trubion Pharmaceuticals, Inc. , today announced it plans to issue earnings results for the first quarter ended March 31, 2008, after the close of market on May 8, 2008. The company's earnings conference call will take place May 8, 2008, at 2 p.m. PDT .
11:03 May 1, 2008
44951 - 44965 of 48601 Stories
<<
<
Next 15 Biotechnology
>
>>
Search News
Daily News
